Navigation Links
Arpida Announces Review of Iclaprim NDA by FDA Advisory Committee in November 2008
Date:10/14/2008

Drug User Fee Act (PDUFA) goal date will be 16 January 2009. Arpida submitted a Marketing Authorisation Application for intravenous iclaprim with EMEA in July 2008. EMEA notified that it had accepted the MAA for review in August 2008.

In December 2007, Arpida announced the enrolment of the first patients in a Phase II clinical study with intravenous iclaprim in the treatment of patients with hospital-acquired pneumonia (HAP), ventilator-associated pneumonia (VAP) or healthcare associated pneumonia (HCAP).

In May 2008, Arpida announced the enrolment of the first patients in a Phase II 'intravenous-to-oral' switch trial. Iclaprim could be offered not only as an intravenous therapy for hospital use in acute situations, but also as an oral formulation, allowing early patient discharge followed by outpatient treatment. This switch could be a valuable instrument in reducing healthcare costs and enhancing patient comfort.

Arpida's fourth most advanced antibiotic programme, AR-709, targets upper and lower respiratory tract infections acquired in the community setting. AR-709 exhibited potent activity against a large panel of pneumococcal clinical isolates including those resistant to currently used drugs. Results of "first-in-man" studies with AR-709 were published in March 2007.

An additional antibacterial compound, AR-2474, has demonstrated in vivo proof of concept. AR-2474 has been shown to be effective in eradicating pathogens in preclinical models of skin infection and nasal carriage.

Apart from the antibiotic programmes, Arpida has an innovative antifungal therapy (TLT) which is in Phase III clinical trials in Europe, targeting onychomycosis.

Moreover, the company has several other leads in optimisation and additional discovery programmes derived from its own discovery platform at various research stages.

This press release contains specific forward-looking statements, e.g. statements including terms like believe, assu
'/>"/>

SOURCE Arpida Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Arpida Completes Enrolment in Phase II "Intravenous-to-Oral" Switch Trial With Oral Iclaprim
2. Arpida Enrols First Patients in "Intravenous-to-Oral" Switch Trial With Oral Iclaprim
3. Arpida Provides Further Comments on the Pivotal Phase III Trials
4. Arpida Invited to Present Data on Iclaprim at Scientific Conference
5. Neurobiological Technologies Announces FDA Agreement to Consolidate Viprinex Phase 3 Trials Accelerating Time to Pivotal Data
6. Facet Solutions Announces Completion of 6 Month Follow-Up in US Pilot Study
7. Quark Pharmaceuticals Announces Publication of Study on Use of siRNA against Proprietary Target for Inhibiting Tumor Growth and Sensitization of Cancer Cells to Chemotherapy
8. XTENT Announces Clinical Trial Data to be Presented at Annual Meeting of Transcatheter Cardiovascular Therapeutics Next Week
9. SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen
10. In celebration of World Hospice and Palliative Care Day, FHSSA Announces Seven New Partnerships Between U.S. Organizations and African Hospices
11. Burcon announces GRAS status for Puratein(R) & Supertein(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... 4, 2015  Neurocrine Biosciences, Inc. (NASDAQ: NBIX ... has joined the company as Vice President, Medical Affairs. ... Dr. Bill Aurora to the Neurocrine team ... Gorman , President and Chief Executive Officer of Neurocrine ... and outreach coupled with his extensive network and influence ...
(Date:5/4/2015)... Microbrush International, a leading developer, producer and ... procedures, today announced the acquisition of DentiSmart LLC. ... matrix system used in dental restorative procedures. ... to add DentiSmart to our growing portfolio of ... and General Manager of Microbrush. "DentiSmart,s products are ...
(Date:5/4/2015)... , May 4, 2015  The board of directors of ... a dividend for the second quarter of 2015 of $0.50 ... dividend is payable June 10, 2015, to shareholders of record ... About Eli Lilly and Company Lilly is a global healthcare ... for people around the world. We were founded more than ...
Breaking Medicine Technology:Neurocrine Biosciences, Inc. Announces Appointment of Dr. Bill Aurora as Vice President, Medical Affairs 2Neurocrine Biosciences, Inc. Announces Appointment of Dr. Bill Aurora as Vice President, Medical Affairs 3Microbrush International Announces Acquisition of DentiSmart 2
... Lexicon Pharmaceuticals, Inc. (Nasdaq: ... treatments for human disease, announced today that Arthur ... executive officer, will present at the Stifel Nicolaus Healthcare ... 2:40 p.m. Eastern Time.  Dr. Sands will provide an ...
... Aug. 30, 2011 Reportlinker.com announces that a ... its catalogue: Specialty Pharmaceutical ... http://www.reportlinker.com/p0512130/Specialty-Pharmaceutical-Industry---2011-Yearbook.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology Summary ... Industry - 2011 Yearbook" essentially provides insights ...
Cached Medicine Technology:Lexicon Pharmaceuticals to Present at Stifel Nicolaus Healthcare Conference 2Specialty Pharmaceutical Industry - 2011 Yearbook 2Specialty Pharmaceutical Industry - 2011 Yearbook 3Specialty Pharmaceutical Industry - 2011 Yearbook 4Specialty Pharmaceutical Industry - 2011 Yearbook 5Specialty Pharmaceutical Industry - 2011 Yearbook 6Specialty Pharmaceutical Industry - 2011 Yearbook 7Specialty Pharmaceutical Industry - 2011 Yearbook 8Specialty Pharmaceutical Industry - 2011 Yearbook 9Specialty Pharmaceutical Industry - 2011 Yearbook 10Specialty Pharmaceutical Industry - 2011 Yearbook 11Specialty Pharmaceutical Industry - 2011 Yearbook 12Specialty Pharmaceutical Industry - 2011 Yearbook 13Specialty Pharmaceutical Industry - 2011 Yearbook 14Specialty Pharmaceutical Industry - 2011 Yearbook 15Specialty Pharmaceutical Industry - 2011 Yearbook 16
(Date:5/5/2015)... (PRWEB) May 05, 2015 With the advent ... and enjoying the feel of warm breezes on bare skin. ... strategies on how to look their best in shorts, tank ... and more people are turning to laser treatments for permanent ... of Simply Posh Aesthetic Spa . “They're all veterans ...
(Date:5/5/2015)... 05, 2015 “We currently have larger size casual ... Phillips, owner of SunGrubbies.com. “We felt it was time to ... a fashionable sun hat in an extra large size that they ... Fashionable derby sun hats such as the Rebecca, Chloe, ... now available in an extra large size , fitting heads ...
(Date:5/5/2015)... There have been numerous attempts to ... on personal lines (home, auto, etc). Now, for the ... (NDOI.com) has created an online vehicle for more than ... present their expertise in all realms of insurance directly ... and two-fold. , First, the online, searchable database improves ...
(Date:5/5/2015)... NY (PRWEB) May 05, 2015 No one ... Centers for Disease Control and Prevention cite multiple ... our everyday life: “Poor indoor air quality (pollution) can bother ... chronic heart and lung problems and cancer.” , Toxic chemicals ... them in contaminated food or water, or in some cases, ...
(Date:5/4/2015)... 2015 Visiopharm, the leader in image ... of a private round of financing with NorthCap ... investment will assist Visiopharm to further accelerate business growth ... image analysis driven diagnostic digital pathology solutions. , "It ... ONCOtopix™ Dx solution has energized the pathologists, and ...
Breaking Medicine News(10 mins):Health News:Laser Hair Removal: Tips for Summertime Grooming 2Health News:Laser Hair Removal: Tips for Summertime Grooming 3Health News:SunGrubbies.com, a Leading Online Retailer of Sun Protection Products, Launches Their New Extra Large Size Fashion Sun Hats Collection 2Health News:NDOI Launch Brings Commercial Insurance Online for the First Time 2Health News:NDOI Launch Brings Commercial Insurance Online for the First Time 3Health News:revitaRUGS is Offering Area Rug Cleaning Discounts in Support of Asthma and Allergy Awareness Month This May 2Health News:revitaRUGS is Offering Area Rug Cleaning Discounts in Support of Asthma and Allergy Awareness Month This May 3Health News:Visiopharm Closes Investment Round to Grow Diagnostic Digital Pathology Business 2Health News:Visiopharm Closes Investment Round to Grow Diagnostic Digital Pathology Business 3
... have to wait for access to public health care.// ... the mandatory three-month waiting period for OHIP coverage for the ... George Smitherman the evacuees have undergone a lot of stress ... they need when they need it the most." ...
... conference of Health Ministers of Southern States will be ... taken for controlling chikungunya,Karnataka Health Minister R Ashok said ... of submitting a memorandum to the Centre seeking financial ... ,The Karnataka government had decided to provide fogging ...
... study carried out by a group of researchers, at ... link between periodontal bacteria and acute// coronary syndrome (ACS). ... of alveolar bone loss was significantly greater among those ... of the study participants in the ACS group showed ...
... surgery permanently damaging your eye? AIIMS has introduced a ... near or far sightedness through the insertion of small ... typical vision correction procedure using intrastromal corneal rings (INTACS) ... of the eye and inserting two crescent shaped rings ...
... of people living with HIV/AIDS in the country do ... United Nations study has said. // ,"Seventy-four ... HIV-positive status at their workplace. Of the remaining 26 ... cent have reported facing discrimination at the hands of ...
... the classroom to keep school-age children and teens from lighting ... is little strong evidence that school-based programs are effective in ... said Dr. Roger Thomas, lead reviewer and a professor in ... Alberta, Canada. ,The review appears in the July ...
Cached Medicine News:Health News:Students Light Up Despite School Anti-Smoking Programs 2Health News:Students Light Up Despite School Anti-Smoking Programs 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: